XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - shares
3 Months Ended
Mar. 31, 2022
May 09, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2022  
Document Transition Report false  
Entity File Number 001-36783  
Entity Registrant Name BELLICUM PHARMACEUTICALS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-1450200  
Entity Address, Address Line One 3730 Kirby Drive,  
Entity Address, Address Line Two Suite 1200,  
Entity Address, City or Town Houston,  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77098  
City Area Code 281  
Local Phone Number 454-3424  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol BLCM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   8,609,661
Entity Central Index Key 0001358403  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Amendment Flag false